Zhenrong Tang

585 total citations
30 papers, 309 citations indexed

About

Zhenrong Tang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Zhenrong Tang has authored 30 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Zhenrong Tang's work include Breast Cancer Treatment Studies (8 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Risks and Factors (5 papers). Zhenrong Tang is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Risks and Factors (5 papers). Zhenrong Tang collaborates with scholars based in China, Germany and Belgium. Zhenrong Tang's co-authors include Shengchun Liu, Yang Peng, Beige Zong, Fanli Qu, Rui Chen, Yihua Wang, Haochen Yu, Hua Tang, Dan Shu and Shaoying Yan and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Zhenrong Tang

29 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenrong Tang China 12 139 132 93 82 35 30 309
Aimin Zang China 10 115 0.8× 132 1.0× 189 2.0× 75 0.9× 50 1.4× 32 372
Wanting Hou China 9 121 0.9× 55 0.4× 108 1.2× 73 0.9× 36 1.0× 15 289
Fanqin Bu China 13 95 0.7× 132 1.0× 252 2.7× 75 0.9× 50 1.4× 28 393
Zhen Cai China 12 234 1.7× 219 1.7× 176 1.9× 66 0.8× 36 1.0× 18 437
Kang Qin China 10 165 1.2× 129 1.0× 151 1.6× 223 2.7× 33 0.9× 18 393
Siwei Ju China 9 92 0.7× 154 1.2× 195 2.1× 79 1.0× 44 1.3× 17 355
Qianling Zhu China 7 128 0.9× 96 0.7× 273 2.9× 61 0.7× 18 0.5× 8 383
Zhaoliang Liu China 11 97 0.7× 141 1.1× 226 2.4× 68 0.8× 55 1.6× 17 420
Dechun Liu China 10 90 0.6× 118 0.9× 139 1.5× 74 0.9× 108 3.1× 16 364
Wang Gaoren China 5 104 0.7× 167 1.3× 185 2.0× 112 1.4× 37 1.1× 7 362

Countries citing papers authored by Zhenrong Tang

Since Specialization
Citations

This map shows the geographic impact of Zhenrong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenrong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenrong Tang more than expected).

Fields of papers citing papers by Zhenrong Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenrong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenrong Tang. The network helps show where Zhenrong Tang may publish in the future.

Co-authorship network of co-authors of Zhenrong Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenrong Tang. A scholar is included among the top collaborators of Zhenrong Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenrong Tang. Zhenrong Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ming-Jia, et al.. (2025). Design of acidic activation-responsive charge-switchable carbon dots and validation of their antimicrobial activity. RSC Advances. 15(7). 5413–5425. 1 indexed citations
2.
Tang, Zhenrong, et al.. (2025). Effects of laser shock peening on the surface integrity and fatigue properties of 34CrNiMo6 steel. Proceedings of the Institution of Mechanical Engineers Part B Journal of Engineering Manufacture. 239(14). 2044–2056.
3.
Du, Haifeng, et al.. (2024). Wear mechanism and three-phase synergistic effect of self-mated SiC/Si/graphite composites in unlubricated sliding. Wear. 564-565. 205674–205674. 1 indexed citations
4.
5.
Tang, Zhenrong, et al.. (2023). Characterization of starvation response‐related genes for predicting prognosis in breast cancer. Cancer Science. 114(8). 3144–3161. 1 indexed citations
6.
Tang, Zhenrong, et al.. (2022). Study of the Antimicrobial Activity of the Chinese Dong Ethnic Minority Medicine, Madeng’ai. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 2 indexed citations
7.
Xu, Yingkun, Han Li, Zhenrong Tang, et al.. (2022). Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology. 2022. 1–15. 17 indexed citations
8.
Xu, Yingkun, Dan Shu, Meiying Shen, et al.. (2022). Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of Immunology Research. 2022. 1–22. 9 indexed citations
9.
Tang, Zhenrong, et al.. (2022). Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer. Journal of Personalized Medicine. 13(1). 44–44. 4 indexed citations
10.
Liu, Qiang, et al.. (2022). A dual‐targeting near‐infrared biomimetic drug delivery system for HBV treatment. Journal of Medical Virology. 95(1). e28312–e28312. 8 indexed citations
11.
12.
13.
14.
15.
Peng, Yang, Haochen Yu, Fanli Qu, et al.. (2021). A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma. Scientific Reports. 11(1). 17610–17610. 24 indexed citations
16.
Tian, Jiao, Zhenrong Tang, Yu Wang, et al.. (2020). Prognostic value of programmed cell death ligand-1 expression in breast cancer. Medicine. 99(49). e23359–e23359. 6 indexed citations
17.
Qu, Fanli, Rui Chen, Yang Peng, et al.. (2020). Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Journal of Breast Cancer. 23(3). 246–246. 8 indexed citations
18.
Peng, Yang, Rui Chen, Fanli Qu, et al.. (2019). Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients. Cancer Biology & Therapy. 21(2). 189–196. 32 indexed citations
19.
20.
Fasching, PA, Guy Jérusalem, Xavier Pivot, et al.. (2016). Phase III study of Ribociclib (LEE011) in combination with Fulvestrant for the treatment of postmenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) who have received no or only one line of prior endocrine treatment : MONALEESA-3. Clinical Cancer Research. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aimin Zang Breakdown of academic impact, for papers by Wanting Hou Breakdown of academic impact, for papers by Fanqin Bu Breakdown of academic impact, for papers by Zhen Cai Breakdown of academic impact, for papers by Kang Qin Breakdown of academic impact, for papers by Siwei Ju Breakdown of academic impact, for papers by Qianling Zhu Breakdown of academic impact, for papers by Zhaoliang Liu Breakdown of academic impact, for papers by Dechun Liu Breakdown of academic impact, for papers by Wang Gaoren
Rankless by CCL
2026